Questions Persist Following FDA's Approval of OxyContin for Kids

at 9:30 AM
 (Joe Raedle/Getty Images)

The U.S. Food and Drug Administration recently approved the painkiller OxyContin for patients aged 11 years and older who suffer from severe, long-term pain. Supporters of the FDA's move say it will ease the suffering of children who have no other treatment options and provide physicians with improved dosing and safety information. But critics say that prescribing OxyContin to youth puts them at risk for addiction.

Guests:

Andrew Kolodny, executive director of Physicians for Responsible Opioid Prescribing and chief medical officer of Phoenix House, the drug and alcohol addiction rehabilitation organization

Nirav Pandya, pediatric orthopedic surgeon, UCSF Benioff Childrens Hospital Oakland

Sponsored

Sponsored

Volume
KQED Live
Live Stream
Log In ToPledge-Free Stream
LATEST NEWSCAST
KQED
NPR
Live Stream information currently unavailable.
Share
LATEST NEWSCAST
KQED
NPR
KQED Live

Live Stream

Live Stream information currently unavailable.